Dronedarone induces regression of coronary artery remodeling related to better global antioxidant status-Reference-Cited by-同舟云学术

Dronedarone induces regression of coronary artery remodeling related to better global antioxidant status

Published:2019-04-16 Issue:10 Volume:42 Page:1485-1494
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

Quintana-Villamandos Begoña,Pazó-Sayós Laia,Arribas Silvia Magdalena,Rodríguez-Rodríguez Pilar,Böger Rainer H.,Lüneburg Nicole,Delgado-Baeza Emilio,González Maria Carmen

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Link

http://www.nature.com/articles/s41440-019-0257-z.pdf

Reference54 articles.

1. Tadros R, Nattel S, Andrade JG. Dronedarone: basic pharmacology and clinical use. Card Electrophysiol Clin. 2016;8:453–65.

2. Lee EJ, Kim J. Evaluation of dronedarone as a therapeutic option for patients with atrial fibrillation. J Clin Pharm Ther. 2014;39:112–7.

3. Quintana-Villamandos B, Gomez de Diego JJ, Delgado-Martos MJ, Muñoz-Valverde D, Soto-Montenegro ML, Desco M, et al. Dronedarone produces early regression of myocardial remodelling in structural heart disease. PLoS ONE. 2017;12:e0188442.

4. Camici PG, Olivotto I, Rimoldi OE. The coronary circulation and blood flow in left ventricular hypertrophy. J Mol Cell Cardiol. 2012;52:857–64.

5. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension. 2001;38:581–7.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of dronedarone vs. placebo on atrial fibrillation progression: apost hocanalysis from ATHENA trial;EP Europace;2023-02-09

2. Maintenance over Time of the Effect Produced by Esmolol on the Structure and Function of Coronary Arteries in Hypertensive Heart Diseases;Antioxidants;2022-10-17

3. Effect of DrOnedarone on atrial fibrosis progression and atrial fibrillation recurrence postablation: Design of the EDORA randomized clinical trial;Journal of Cardiovascular Electrophysiology;2021-11-02

4. OXY-SCORE: a new perspective for left ventricular hypertrophy diagnosis;Therapeutic Advances in Chronic Disease;2020-01